This is not a real company, but there is another company called Synergen that made Antril.  In 1992 the company was hopeful that the drug was going to make a big impact, and they were a significant player in the Biochemistry world. After Antril seemed to be positively impacting people in their 99-person test trial, they moved on to a bigger group of people, 900. During this trial, the Antril only worked about 3% better than the placebo used. Upon the failure of this trial, the company's shares dropped by 70%. After two more years of failed trials of the treatment, Synergen cut its staff in half and was purchased by its successful counterparts, Amgen in 1994 for $240 million.